Pheromone cCF10 inhibits the antibiotic persistence of Enterococcus faecalis by modulating energy metabolism

Zhu Li, Xiaobo Yang, Xinyue Fu, Panpan Yang, Xiaoli Lin, Feng Wang, Zhiqiang Shen, Jingfeng Wang, Feilong Sun, Zhigang QiuFrontiers in Microbiology 2024 · DOI

Abstract

The metabolically active E. faecalis OG1RF reached a persistence state and temporarily tolerated lethal antibiotic concentrations after 8 h of levofloxacin hydrochloride (20 mg/mL) exposure, exhibiting a persistence rate of 0.109 %. During the growth of E. faecalis OG1RF, biofilm formation was a critical factor contributing to antibiotic persistence, whereas 10 ng/mL cCF10 blocked persister cell formation. Notably, cCF10 mediated the antibiotic persistence of E. faecalis OG1RF via regulating metabolic activity rather than suppressing biofilm formation. The addition of cCF10 stimulated the Opp system and entered bacterial cells, inhibiting (p)ppGpp accumulation, thus maintaining the metabolically active state of bacteria and reducing persister cell generation. These findings offer valuable insights into the formation, as well as the control mechanism of E. faecalis persisters.

Introduction

While antibiotic resistance—driven by genetic mutations—is a well-known global health threat, antibiotic persistence presents an equally challenging obstacle to treating chronic infections. Persisters are a small subpopulation of genetically susceptible bacteria that enter a dormant, non-growing state. Because most antibiotics target active cellular processes like cell wall synthesis or DNA replication, these "sleeping" cells survive treatment and can "wake up" once the antibiotic pressure is removed, leading to recurrent infections.

Enterococcus faecalis is a major cause of hospital-acquired infections and is notoriously difficult to treat due to its robust cell wall and biofilm-forming capabilities. This study, published in Frontiers in Microbiology (July 2024), investigates how the sex pheromone cCF10 influences this persistence state.

Methods and Materials

The researchers utilized E. faecalis OG1RF and a mutant strain ($\Delta ccfA$) unable to produce the cCF10 pheromone. The study employed several key techniques:

  • Biphasic Killing Curves: Exposure to lethal Levofloxacin (20 mg/mL) to quantify persisters.
  • Transcriptome Sequencing (RNA-seq): Analysis of gene expression differences (Data deposited under PRJCA026007).
  • Metabolic and Morphological Assays: Measuring intracellular ATP levels and using Scanning Electron Microscopy (SEM) to observe physical changes in cells and biofilms.

Results: The Metabolic "Wake-Up Call"

The study revealed that cCF10 acts as a metabolic regulator that prevents bacteria from entering dormancy. By stimulating the Opp transport system and inhibiting the accumulation of the "alarmone" (p)ppGpp, cCF10 maintains high metabolic activity and DNA replication, keeping the bacteria susceptible to antibiotics.

Figure 1: Quantitative persistence data and SEM morphological analysis of E. faecalis. Panel A shows the concentration-dependent effect of cCF10. Panel B shows the increased persistence in the ΔccfA mutant and its rescue. Panel C displays SEM images of the bacterial populations.

Key Findings:

  • Baseline Persistence: E. faecalis OG1RF showed a persistence rate of 0.109%, significantly higher than typical E. coli rates.
  • Pheromone Inhibition: 10 ng/mL of cCF10 reduced the persister rate to approximately 0.05%.
  • Mutant Vulnerability: The $\Delta ccfA$ mutant exhibited a higher persistence rate (0.31%), which was reversed by exogenous cCF10.
  • Concentration Paradox: While low concentrations (10–12 ng/mL) inhibited persistence, higher doses (>14 ng/mL) actually increased it, possibly due to physiological stress.

Discussion and Future Directions

The discovery that cCF10 works independently of biofilm physical structures—instead targeting intracellular metabolic "brakes"—opens new avenues for "anti-persister" therapies. However, several hurdles remain:

  1. Clinical Application: cCF10 naturally induces the transfer of antibiotic resistance genes; therapeutic use would require decoupling this effect from its metabolic "wake-up" function.
  2. In Vivo Validation: The study was conducted in vitro; host-environment factors must be considered.
  3. Dose Response: The mechanism behind the increased persistence at high pheromone concentrations requires further investigation.

Future research should also explore whether cCF10 sensitizes E. faecalis to other antibiotic classes, such as vancomycin.

Summary updated

Abstract

The metabolically active <i>E. faecalis</i> OG1RF reached a persistence state and temporarily tolerated lethal antibiotic concentrations after 8 h of levofloxacin hydrochloride (20 mg/mL) exposure, exhibiting a persistence rate of 0.109 %. During the growth of <i>E. faecalis</i> OG1RF, biofilm formation was a critical factor contributing to antibiotic persistence, whereas 10 ng/mL cCF10 blocked persister cell formation. Notably, cCF10 mediated the antibiotic persistence of <i>E. faecalis</i> OG1RF via regulating metabolic activity rather than suppressing biofilm formation. The addition of cCF10 stimulated the Opp system and entered bacterial cells, inhibiting (p)ppGpp accumulation, thus maintaining the metabolically active state of bacteria and reducing persister cell generation. These findings offer valuable insights into the formation, as well as the control mechanism of <i>E. faecalis</i> persisters.
BibTeX
@inproceedings{li2024pheromone,
  author = {Zhu Li and Xiaobo Yang and Xinyue Fu and Panpan Yang and Xiaoli Lin and Feng Wang and Zhiqiang Shen and Jingfeng Wang and Feilong Sun and Zhigang Qiu},
  title = {{Pheromone cCF10 inhibits the antibiotic persistence of Enterococcus faecalis by modulating energy metabolism}},
  booktitle = {Frontiers in Microbiology},
  year = {2024},
  doi = {10.3389/fmicb.2024.1408701},
}
Figure